Research Progress in the Role of Tim3/galectin-9 in Hematological Malignancy--Review

Category Primary study
JournalJournal of Experimental Hematology
Year 2021
The incidence of hematological malignant tumor is increasing year by year, and seriously affecting the human health. In addition to the traditional radiation and chemotherapy, immunotherapy has achieved a certain effect in the treatment of blood tumor, but it is limited by exhaustion of CD8
Epistemonikos ID: 0a7b27201ad76e8563092d0fad82a25eb2808252
First added on: Nov 28, 2024